AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
175.58
+4.06 (2.37%)
Dec 20, 2024, 4:01 PM EST - Market closed
AbbVie Revenue
AbbVie had revenue of $14.46B in the quarter ending September 30, 2024, with 3.83% growth. This brings the company's revenue in the last twelve months to $55.53B, up 0.72% year-over-year. In the year 2023, AbbVie had annual revenue of $54.32B, down -6.44%.
Revenue (ttm)
$55.53B
Revenue Growth
+0.72%
P/S Ratio
5.59
Revenue / Employee
$1,110,660
Employees
50,000
Market Cap
310.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | 33.27B | 513.00M | 1.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 393.90B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher | 42.37B |
Abbott Laboratories | 41.22B |
Eli Lilly | 40.86B |
ABBV News
- 2 days ago - Retirement-Ready Income: 5 Dividend Gems I'd Buy If I Were 65 - Seeking Alpha
- 3 days ago - My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys - Seeking Alpha
- 3 days ago - Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo - Business Wire
- 4 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 4 days ago - AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors - Seeking Alpha
- 5 days ago - AbbVie Enters Oversold Territory - Forbes
- 7 days ago - Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value - Seeking Alpha
- 8 days ago - AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline - PRNewsWire